Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

HDAC inhibitor MS-275 active against pediatric solid tumors in vitro and in vivo

Jan. 7, 2003

Velcade enters phase II trial in colorectal cancer

Jan. 7, 2003

Cytogen regains rights to ex vivo prostate cancer immunotherapy

Jan. 7, 2003

Results reported for NBI-3001 in glioblastoma

Jan. 7, 2003

Phase I interim safety data reported for Reolysin in malignant glioma

Jan. 7, 2003

Azido-based photosensitizers covered by Mallinckrodt patent

Jan. 3, 2003

Potential antileukemia agents selected from series of arsonic acids

Jan. 3, 2003

Inhibition of tight junction function as a novel approach to breast cancer

Jan. 3, 2003

SuperGen submits first module of rolling NDA for Orathecin

Jan. 3, 2003

Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs

Jan. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...